Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial – The Lancet Respiratory Medicine Commentary: The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients – News Medical Related: Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial […]

The post RCT | Tixagevimab-cilgavimab for treatment of patients hospitalized with COVID-19. appeared first on Links Medicus.